tirzepatide sglt2 is finally here – what's the big deal? – GP Voice Causes and consequences of discontinuation

Tirzepatide is the drug's generic name, but no FDA-approved generic tirzepatide product is on the market as of April 2026

Thats when she saw an opportunity gap

fortunately, serious consequences are rare

She visited her primary care doctor soon after to discuss what to do

While a FETCH questionnaire was not completed on patients, there was an overwhelming owner-noted improvement to the patients' quality of life when optimal dosing of Entresto was achieved based on owner report history during follow-up

[DOI] [PMC free article] [PubMed] [Google Scholar] Kpka A, Chojnowska S, nitko R, Zwierz K, Waszkiewicz N (2016) Renal carnitine excretion following abstinence after chronic drinking